XML 24 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2016
Jan. 31, 2015
Operating activities    
Net loss $ (4,409) $ (181)
Adjustments to reconcile net loss to net cash flows (used in) provided by operating activities    
Depreciation and amortization 5,929 5,897
Gain on disposal of discontinued operations (8,099) (188)
Impairment expense on discontinued operations 6,480 0
Deferred tax (benefit) expense (249) 1,231
Income in joint venture (602) (1,960)
Stock-based compensation expense 278 124
Cash surrender value on life insurance policies 206 (145)
Provision on uncollectible accounts (59) (80)
Loss (gain) on disposal of fixed assets 101 (17)
Changes in operating assets and liabilities    
Accounts payable 5,819 (4,612)
Accrued compensation and payroll taxes 299 (3,055)
Inventories 4,027 3,250
Customers' deposits (2,400) (28)
Income taxes receivable and payable 620 (687)
Prepaid expenses and other current assets 1,914 1,000
Accounts receivable (2,809) 3,314
Costs and estimated earnings in excess of billings on uncompleted contracts (1,268) (765)
Notes receivable 273 849
Other assets and liabilities (8,948) (449)
Net cash (used in) provided by operating activities (2,897) 3,498
Investing activities    
Net proceeds from sale of discontinued operations 16,373 109
Capital expenditures (6,457) (5,878)
Payments on loan from joint venture 1,890 0
Proceeds from sales of property and equipment 2,059 24
Net cash provided by (used in) investing activities 13,865 (5,745)
Financing activities    
Proceeds from revolving lines 105,636 85,270
Proceeds from debt 918 661
Proceeds from borrowing against life insurance policies 1,916 0
Payments of debt on revolving lines (105,378) (83,150)
Payments of other debt (2,544) (3,641)
Payments on borrowing against life insurance policies (1,916) 0
Decrease (increase) in drafts payable (467) 629
Payments on capitalized lease obligations (998) (704)
Repurchase of Common Stock (290) 0
Stock options exercised and restricted shares issued 98 389
Net cash used in financing activities (3,025) (546)
Effect of exchange rate changes on cash and cash equivalents (1,212) (702)
Net increase (decrease) in cash and cash equivalents 6,731 (3,495)
Cash and cash equivalents - beginning of period 9,900 13,395
Cash and cash equivalents - end of period 16,631 9,900
Supplemental cash flow information    
Interest paid 749 1,288
Income taxes paid 970 2,988
Fixed assets acquired under capital leases 0 680
Funds held in escrow related to the sale of Filtration assets $ 1,905 $ 0